Two Sigma Investments’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,863
Closed -$24.4K 3381
2025
Q1
$24.4K Sell
3,863
-337
-8% -$3.15K ﹤0.01% 3090
2024
Q4
$43.3K Sell
4,200
-1,451
-26% -$16K ﹤0.01% 3058
2024
Q3
$72.6K Sell
5,651
-4,166
-42% -$61.2K ﹤0.01% 2931
2024
Q2
$136K Buy
9,817
+6,142
+167% +$694K ﹤0.01% 2790
2024
Q1
$1.14M Buy
3,675
+1,023
+39% +$273K ﹤0.01% 1871
2023
Q4
$695K Buy
2,652
+2,324
+709% +$421K ﹤0.01% 2288
2023
Q3
$64.2K Buy
+328
New +$58.7K ﹤0.01% 2792
2022
Q3
Sell
-270
Closed -$76K 2669
2022
Q2
$76K Buy
+270
New +$73.5K ﹤0.01% 2300
2022
Q1
Sell
-355
Closed -$77K 3628
2021
Q4
$77K Buy
355
+87
+32% +$27.9K ﹤0.01% 4103
2021
Q3
$122K Sell
268
-210
-44% -$79.4K ﹤0.01% 4059
2021
Q2
$192K Sell
478
-963
-67% -$439K ﹤0.01% 3793
2021
Q1
$835K Buy
1,441
+991
+220% +$619K ﹤0.01% 2481
2020
Q4
$257K Buy
+450
New +$254K ﹤0.01% 2974
2020
Q3
Sell
-412
Closed -$234K 3362
2020
Q2
$234K Buy
+412
New +$301K ﹤0.01% 2536

Other funds holding LYRA

Two Sigma Investments's LYRA Position: Q2 2025 in Review

Two Sigma Investments sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 3,863 shares — an estimated $24.4K sold.

Two Sigma Investments first reported a position in LYRA in Q2 2020 and held it in 14 quarters. The position peaked at $1.14M in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Two Sigma Investments reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 3,863 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $24.4K.
  • Two Sigma Investments first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 14 quarters.
  • Two Sigma Investments's LYRA THERAPEUTICS INC position peaked at $1.14M in Q1 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.